Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patients' lives, and lead to a cure.
September is Blood Cancer Awareness Month. Behind every diagnosis is a person, and the people who love them.
Help us spread awareness of the second most common blood cancer: share one thing you wish more people knew about myeloma.
The 10th Annual Road to Victories kicks off in four weeks! We asked this year's participants what motivates them to ride and raise funds for myeloma research.
You can support this year's ride by making a gift today: https://t.co/AnM9TRdvJv
In 1 month, endurance athlete and MMRF supporter Eric Gelber takes on his most relentless challenge yet: 36 hours. 10,000 pushups. 100 miles rowed.
Join us 9/26 at the Chappaqua NY Train Station, follow the journey on social, and support: https://t.co/a9PPdX4FnX
Living with myeloma means making a lot of decisions, and you don't have to make them alone. MMRF co-founder and patient advocate Kathy Giusti shares practical strategies for making confident decisions, preparing for key milestones, and more.
Learn more: https://t.co/ZQHrhKwIyl
Brittany, an MMRF Patient Navigator, explains how your care team monitors the disease, and what the results can tell you along the way.
Find more resources on our website: https://t.co/SasXlPqdEv
The latest issue of Accelerator magazine is here with updates on the latest myeloma research, expert advice on living well, and stories from the community driving it all forward.
Explore the issue: https://t.co/TfLi6456q9
The MMRF Southern California Walk has helped drive a decade of myeloma progress. Join us as we take the next steps toward a cure. Register today: https://t.co/iCxACam9T7
Understanding your risk status is an important part of navigating a myeloma diagnosis. Grace, an MMRF Patient Navigator, explains what "high risk" means and how it can help guide treatment decisions, from combination therapies to clinical trials.
For more: https://t.co/UXehOvWmgZ
Today the FDA announced approval of Zenbexus (iberdomide), in combination with Darzalex (daratumumab) and dexamethasone, for patients whose multiple myeloma has returned after one or more previous treatments. Here's what patients should know: https://t.co/DJO1pG9sUe
The latest Multiple Myeloma Hub Steering Committee meeting included a discussion on integrating BCMA-directed bispecific antibodies into routine and community-based care for #MultipleMyeloma.
Learn more: https://t.co/Kzfz1w3wDZ
#myeloma#mmsm
Transitioning BCMA-directed bispecific antibodies into community practice has the potential to improve access and convenience, but requires appropriate infrastructure, training, and multidisciplinary coordination.
Watch the full video here: https://t.co/oid3HHdp9x
#MultipleMyeloma #mmsm #myeloma #MedEd @MilesPrince4
August is Make-a-Will Month.
In 20 minutes, you can protect your loved ones and leave a legacy for the myeloma community. We've teamed up with @FreeWill_HQ to make it free and easy.
Your impact can help accelerate a cure. Start today: https://t.co/gmJrH7Qj6t
Five years ago, Bheka Khumalo was diagnosed with multiple myeloma. Next March, he'll run the Tokyo Marathon, his third with MMRF Team for Cures. He's running for a world free of myeloma. 💪 Your next race could, too: https://t.co/hi1YpkuyQW
For relapsed myeloma patients, determining the right combination, sequence, and duration of treatment remains a challenge. Horizon One is designed to address those questions quicky—it's already six months ahead of schedule.
Read more: https://t.co/Qq9DknDm8Z
When Mike Cullen Johnson gets on his bike, he's riding to raise funds for more myeloma treatments, and eventually a cure. He's been there himself, and he's seen what research can do.
That research is possible thanks to supporters like you. Give today: https://t.co/eu6Z3u5nzn
Data drives cures, so for 20 years the MMRF has shared our data openly. The result: 250+ discoveries.
Now comes the next big step with MMRF Virtual Lab, myeloma's largest data-sharing platform. https://t.co/LE1mUOprjL
Three years ago, Mike Cullen Johnson was blindsided by a multiple myeloma diagnosis. Now he's in remission and raising funds for other myeloma patients.
Read more about Mike's story: https://t.co/9w04R9oevM